Literature detail

Prevalence of anti-severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease-19 pandemic.

Julia Maria Adler1,2 Corinna Weber2 Kerstin Wernike3 Anna Michelitsch3 Karin Friedrich2 Jakob Trimpert1 Martin Beer3 Barbara Kohn4 Klaus Osterrieder1,5 Elisabeth Müller2
Affiliations 5 institutions
  1. Institut für Virologie, Freie Universität Berlin, Berlin, Germany.
  2. Laboklin GmbH & Co.KG, Bad Kissingen, Germany.
  3. Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
  4. Klinik für kleine Haustiere, Freie Universität Berlin, Berlin, Germany.
  5. Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong.
PMID 35238485 2022 Zoonoses Public Health eng ppublish
PubMed DOI Browse context

Article

Publication summary

During the first months of the coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), cases of human-to-cat transmission were reported. Seroconversion was shown in cats infected under experimental and natural conditions. This large-scale survey of 1,005 serum samples was conducted to investigate anti-SARS-CoV-2 antibody prevalence in domestic cats during the first 7 months of the pandemic in Germany and other European countries. In addition, we compared the sensitivity and specificity of two multispecies SARS-CoV-2 antibody enzyme-linked immunosorbent assays (ELISA). Results were confirmed by using an indirect immunofluorescence test (iIFT) and a surrogate virus neutralization test (sVNT). Sera that were highly positive for feline coronavirus (FCoV) antibodies (n = 103) were included to correct for cross-reactivity of the tests used. Our results showed an overall SARS-CoV-2 seropositivity of 1.9% (n = 19) in a receptor-binding domain (RBD)-based ELISA, additional 0.8% (n = 8) were giving inconclusive results. In contrast, a nucleocapsid-based ELISA revealed 0.5% (n = 5) positive and 0.2% (n = 2) inconclusive results. While the iIFT and sVNT confirmed 100% of positive and 50%-57.1% of the doubtful results as determined in the RBD ELISA, the nucleocapsid-based assay showed a high discrepancy and only one of the five positive results could be confirmed. The results indicate significant deficits of the nucleocapsid-based ELISA with respect to sensitivity and specificity. Due to a significantly higher rate (5.8%) of positive results in the group of highly FCoV antibody-positive samples, cross-reactivity of the FCoV-ELISA with SARS-CoV-2 antibodies cannot be excluded. Furthermore, we investigated the impact of direct contact of domestic cats (n = 23) to SARS-CoV-2 positive owners. Considering one inconclusive result, which got confirmed by iIFT, this exposure did not lead to a significantly higher prevalence (4.4%; p = .358) among tested subjects. Overall, we conclude that cats are a negligible entity with respect to virus transmission in Europe.

cats COVID-19 SARS-CoV-2 seroprevalence Cat Diseases COVID-19 Animals Antibodies, Viral Cats Enzyme-Linked Immunosorbent Assay Humans Pandemics Prevalence SARS-CoV-2

Structured evidence records

Evidence records

3 total
1 records
Extraction confidence 1.00
Key finding

Domestic cats in Germany and other European countries showed 1.9% seropositivity for SARS-CoV-2 antibodies based on a receptor-binding domain ELISA.

Virus
Location
Not specified
Supporting text

This large-scale survey of 1,005 serum samples was conducted to investigate anti-SARS-CoV-2 antibody prevalence in domestic cats during the first 7 months of the pandemic in Germany and other European countries... Our results showed an overall SARS-CoV-2 seropositivity of 1.9% (n = 19) in a receptor-binding domain (RBD)-based ELISA.

Method
ELISA; indirect immunofluorescence test; surrogate virus neutralization test
Sample type
serum
1 records
Extraction confidence 0.90
Key finding

Human-to-cat transmission of SARS-CoV-2 occurred during the early phase of the COVID-19 pandemic, with cats showing seroconversion after exposure to infected owners.

Virus
Location
Supporting text

During the first months of the coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), cases of human-to-cat transmission were reported.

Method
ELISA; indirect immunofluorescence test; surrogate virus neutralization test
Study design
serological survey
Transmission direction
human-to-animal
Geographic raw
Germany and other European countries
1 records
Extraction confidence 0.85
Key finding

Serological surveillance detected a low prevalence of anti-SARS-CoV-2 antibodies in domestic cats in Germany and other European countries early in the COVID-19 pandemic.

Virus
Location
Supporting text

This large-scale survey of 1,005 serum samples was conducted to investigate anti-SARS-CoV-2 antibody prevalence in domestic cats during the first 7 months of the pandemic in Germany and other European countries.

Method
ELISA; indirect immunofluorescence test; surrogate virus neutralization test
Sample type
serum
Geographic raw
Germany and other European countries
Country inferred
Germany